SEC Comment Letter for Ernexa Therapeutics Inc. (ERNA, ERNAW) (CIK 0000748592) (ERNA) — Sep 1, 2005

Ernexa Therapeutics Inc. (ERNA, ERNAW) (CIK 0000748592)
Date: Sept. 1, 2005 · CIK: 0000748592 · Accession: 0000000000-05-045577

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

August 10, 2005

Author

/s/ Larry Spirgel

Form

UPLOAD

Company

Ernexa Therapeutics Inc. (ERNA, ERNAW) (CIK 0000748592)

Letter

Mail Stop 3561 August 10, 2005 Via U.S. Mail and Fax (760) 930-1178 Mr. Andy Wrobel Chief Financial Officer NTN Communications, Inc. 5966 La Place Court Carlsbad, CA 92008

RE: NTN Communications, Inc. Form 10-K for the fiscal year ended December 31, 2004 Filed March 16, 2005 Amended May 2, 2005 File No. 1-11460

Dear Mr. Wrobel:

We have completed our review of your 2004 Form 10-K and related filings and do not, at this time, have any further comments.

Sincerely,
/s/ Larry Spirgel
Assistant Director

Show Raw Text

<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>

Mail Stop 3561
      							August 10, 2005

Via U.S. Mail and Fax  (760) 930-1178
Mr. Andy Wrobel
Chief Financial Officer
NTN Communications, Inc.
5966 La Place Court
Carlsbad, CA  92008

	RE:	NTN Communications, Inc.
      Form 10-K  for the fiscal year ended December 31, 2004
		Filed March 16, 2005
		Amended May 2, 2005
		File No. 1-11460

Dear Mr. Wrobel:

	We have completed our review of your 2004 Form 10-K and
related
filings and do not, at this time, have any further comments.

							Sincerely,

							/s/ Larry Spirgel
							Assistant Director

??

??

??

??

Mr. James B. Frakes
NTN Communications, Inc.
May 24, 2005
Page 1

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

         DIVISION OF
CORPORATION FINANCE

100 F Street, N.E. Washington, D.C. 20549   202-551-3810

</TEXT>
</DOCUMENT>

SecProbe.io